Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Gynecol Oncol. 2016 Jun 4;142(2):217–224. doi: 10.1016/j.ygyno.2016.05.035

Table 4.

Progression-free survival (PFS) and overall survival (OS) in patients who did and did not undergo a diverting ileostomy

Median PFS
(mo)
95% CI p Median OS (mo) 95% CI p

Entire cohort 18.4 16.4 – 20.5 -- 59.6 48.6 – 70.6 --

Ileostomy
  No 18.6 16.1 – 21.2 .88 63.8 52.2 – 75.3 .25
  Yes 17.9 14.1 – 21.8 48.7 34.5 – 63.0

Median
follow-up
52.6 months (range, 0.7–123.2)